Experts in human tissue and iPSC research
REPROCELL is a global leader providing a unique combination of induced pluripotent stem cells (iPSC) and human tissue products. With scientists on three continents, they have the global reach and expertise to better translate your discoveries into therapies. They were the first company to offer iPSC-derived human cardiomyocytes, hepatocytes and neuronal cells for research. It has since expanded its product range by acquisition of BioServe, Biopta, Stemgent, KOKEN, and Alvetex.
Bio-Connect Life Sciences supplies all their products in the Benelux. If you have any questions, please contact the helpdesk.
Major product lines from REPROCELL
- BioServe: Commercial biorepository
- Stemgent: iPSC technologies, reagents, and cell lines
- Alvetex: 3D cell culture and labware
The Stemgent brand is well known in the global stem cell research community.
They have become associated with stem cell performance-qualified reagents and innovation after becoming the first company to launch a mRNA reprogramming kit for making iPSCs. Today, the organization is armed with broader capabilities and expertise, and has recently developed a third generation reprogramming technology (StemRNA 3rd Gen RNA Reprogramming) which is now available through iPSC reprogramming services. All of this, combined with complementary REPROCELL know-how from across the globe, uniquely positions the organization with a full-range of iPSC services including:
- iPSC reprogramming
- Neuronal differentiation
- iPSC expansion, characterization, and banking
KOKEN® Atelocollagen (AteloCell®)
The KOKEN atelocollagen (AteloCell®) products are all made from highly purified bovine collagen and supplied in various configurations for a variety of uses. The scaffolds, sponges and membranes are made from purified natural materials and support the 3D growth of mammalian cells.
Atelocollagen is a truncated, non-immunogenic form of bovine Type 1 collagen (derived from skin), and consequently can be used as a cell growth scaffold for in vitro culture and subsequent in situ implantation into lab animals.